Our website uses its own and third parties cookies for a high level of user-friendliness. If you continue to browse and  use this website we will assume that you agree with the policies.

COVID-19

COVID-19

  • Covid-19 Tests
  • Companies
  • Individuals
  • Online consultations Covid-19

Atrys HealthAtrys

  • Español
  • English

Main navigation

  • Company
    • Presentation
    • Mission, vision and values
  • Laboratory
    • Laboratory
    • Test directory
    • Clinical trials and R&D services
    • Quality
    • Team
  • Telemedecine
    • What is telemedicine?
    • Radiology
    • Cardiology Cardiology
    • Ophthalmology
    • Dermatology
  • Radiotherapy
  • R&D
    • R&D
    • LIQUID BIOPSY
    • PROGNOSTIC ALGORITHMS
    • DATA INTEGRATION PLATFORMS
    • ONLINE DIAGNOSIS
    • OTHER PROJECTS
    • R&D services and training agreements
    • Publications and patents
  • Investors
  • News
  • Contact
    • Work with us
  • Private area

  • Español
  • English
  • Company
    • Presentation
    • Mission, vision and values
  • Laboratory
    • Laboratory
    • Test directory
      • Anatomic Pathology
      • Cytology
      • Hematology
      • Diagnostic Second Opinion
    • Clinical trials and R&D services
    • Quality
    • Team
  • Telemedecine
    • What is telemedicine?
    • Radiology
    • Cardiology Cardiology
    • Ophthalmology
    • Dermatology
  • Radiotherapy
  • R&D
    • R&D
    • LIQUID BIOPSY
      • BLI-O
      • S100P
      • Surveprost
      • Aptalung
      • InmunoSIGHT
      • Oncoporecise
      • Glibioliquid
      • Metabreast
      • PREDIAPT
      • ONCLIC
    • PROGNOSTIC ALGORITHMS
      • RADIOPROLIQ
      • 3TR
      • Predictgyn
      • Tradion P
      • Anxarecu
      • Precisesads
      • Oncoexpert
      • Prostatepredict
      • IHC and FISH study of EGFRvIII and PTEN expression in relapsed high grade gliomas
      • Identification of a predictive model for therapeutic guidance in cerebral tumors (gliomas) by means of systems pathology
      • Identificación de un modelo predictivo de opción terapéutica en cáncer de mama mediante la aplicación de la Patología Molecular y de Sistemas
      • Identificación de un modelo predictivo de opción terapéutica en linfomas de célula grande (DLBCL) mediante la aplicación de Patología de Sistemas
    • DATA INTEGRATION PLATFORMS
      • Plataforma de ayuda a la detección temprana de enfermedades infecciosas, mediante la identificación local de patógenos a partir de resultados de analíticas provenientes de laboratorios de análisis mediante técnicas de big data y hacking ético
    • ONLINE DIAGNOSIS
      • Daplia
      • eDCardio
      • eDSalud
      • eHealth areas in Hotels
    • OTHER PROJECTS
      • TheraYAP
      • Gliomatherapy
      • Papiloma
      • Zitomab
      • System of pharmacogenomic evaluation for breast cancer treatment with aromatase inhibitors according to a new application designed by ROVI Laboratories
      • CoVIg3
      • RAP-ID19
    • R&D services and training agreements
    • Publications and patents
      • Methods for prognosis of diffuse large b-cell lymphoma
      • EGFR and PTEN gene alterations predicts survival in patients with brain tumors
      • Monoclonal antibodies for the diagnosis, treatment and/or prevention of brain tumors and brain lesions
  • Investors
  • News
  • Contact
    • Work with us

Private area

MAB - Mercado Alternativo Bursátil

Research and development

  • R&D
  • LIQUID BIOPSY
  • PROGNOSTIC ALGORITHMS
  • DATA INTEGRATION PLATFORMS
  • ONLINE DIAGNOSIS
  • OTHER PROJECTS
  • R&D services and training agreements
  • Publications and patents
  • R&D
  • LIQUID BIOPSY
  • PROGNOSTIC ALGORITHMS
  • DATA INTEGRATION PLATFORMS
  • ONLINE DIAGNOSIS
  • OTHER PROJECTS
  • R&D services and training agreements
  • Publications and patents

Research and development

Atrys has different areas of complementary activity that are closely interrelated, which include the area of translational research.

The main activity of this area is based in collaborations with public research organizations (PROs), referral hospitals, and / or small and medium enterprises (SMEs).

These collaborations support the growth in the portfolio of knowledge of the company, at the same time that are possible thanks to the participation of Atrys entire team, enabling the management and development of diverse active research projects.

  • R&D introduction

Our focus

Atrys has launched diverse R&D projects in collaboration with leading academic and health centers.

In general, our projects focus on the integrated analysis of functional and molecular properties in different human tumor types to define a specific phenotype for each patient, altoghether with the development of models and tools for predicting therapeutic response in oncology that can generate marketable predictive test.

 

Atrys has been recognized as an innovative SME (Pyme Innovadora) by the Ministry of Economy and Competitiveness. This seal, created for small and medium-sized enterprises (SMEs), officially recognizes the effort of our company to research and innovate in the medical sector.

  • Projects

Projects

  • Hemathology

R&D services

  • Articles and patents

Publications and Patents

  • Training

Education

  • R&D
  • LIQUID BIOPSY
  • PROGNOSTIC ALGORITHMS
  • DATA INTEGRATION PLATFORMS
  • ONLINE DIAGNOSIS
  • OTHER PROJECTS
  • R&D services and training agreements
  • Publications and patents
  • R&D
  • LIQUID BIOPSY
  • PROGNOSTIC ALGORITHMS
  • DATA INTEGRATION PLATFORMS
  • ONLINE DIAGNOSIS
  • OTHER PROJECTS
  • R&D services and training agreements
  • Publications and patents
Atrys logo

Atrys Madrid

C/ Velázquez 24, 4ºIzq
28001 Madrid

T: +34 917 819 465

info@atryshealth.com

Atrys Barcelona

C/Provença 392, planta baixa, 
08025, Barcelona

T: +34 934 815 561

info@atryshealth.com

Atrys Granada

Edificio Genyo (PTCS)

Av. Ilustración 114 
18007  Granada

T: +34 958 715 500, ext. 125

info@atryshealth.com

Atrys Lugo

ICM/Atrys Division

Parque empresarial As Gándaras

Rúa María Barbeito, 61
27003 Lugo, España

T: +34 982 240 944
T: +34 902 212 054

Atrys Bogotá

Edificio Global Medical Center

Calle 116 No. 9 - 72, Oficina 410
Bogotá - Colombia

T: (571) 675 0195
T: 316 525 9414
T: 317 517 9533

teleradiologiadecolombia.com

Atrys Santiago de Chile

ITMS/Atrys Division

Av. Gertrudis Echeñique 30
Las Condes 71
Santiago de Chile

T: +56 (2) 2 437 49 04

www.itms.cl

Atrys Sao Paulo

AxisMed/Atrys Division

Avenida das Nações Unidas, 13.797
Bloco II - 18 andar
São Paulo – SP- Brasil

T: +55 11 3513 – 2924

www.portalaxismed.com.br

 

 

Web design | Legal advice